JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis
WHOWHATWHEREWHENWHYNuwellis, Inc., and Dr. Sean P. Pinney and Dr. Maria V. DeVitaUpdated analysis of the AVOID-HF study data shows that Aquadex® ...
Nasdaq3d
Nuwellis, Inc. Reports 60% Reduction in Heart Failure Events with Aquadex® SmartFlow Ultrafiltration Therapy in Updated AVOID-HF Study Analysis
Nuwellis, Inc. has announced updated findings from the AVOID-HF study, indicating that the Aquadex® SmartFlow ultrafiltration therapy significantly reduces heart failure events by 60% compared to ...
Ultrafiltration Market A Comprehensive Study Explores Huge Growth In Future 2025-2031
Ultrafiltration Market Analysis WILMINGTON, DE, UNITED STATES, February 8, 2025 /EINPresswire / -- The rising demand from industrial and munic ...
Nuwellis’ Aquadex SmartFlow therapy shows heart failure reduction in study
Nuwellis (NUWE) highlighted “promising” findings from an updated analysis of the AVOID-HF study, recently published in the Journal of the ...